Currently, the diagnosis of AD and dementia is mainly based on the alteration of specific pathological proteins (such as amyloid and tau proteins) in the central nervous system (CNS) and impaired cognitive functions [3, 4]. Here, MAPT is linked to Alzheimer disease.